Skip to content

Balanced Volume Replacement Therapy With Ringer's Acetate Solution in Burn Injury

Balanced Volume Replacement Therapy With Ringer's Acetate Solution in Burn Injury

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00609700
Acronym
VoLTRAB
Enrollment
82
Registered
2008-02-07
Start date
2007-12-31
Completion date
2010-12-31
Last updated
2011-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Burn Injury

Keywords

burn injury, volume replacement, Ringer's Lactate solution, Ringer's Acetate solution, volume replacement with crystalloids

Brief summary

This observational study compares the influence of Ringer's Lactate solution and Ringer's Acetate solution on organ function scores following severe burn injury.

Detailed description

In the early period following severe burn injury volume replacement with high amounts of crystalloids is necessary. In this study we compare the organ function scores of a historical patient group, treated with Ringer's Lactate solution, with an actual patient population, treated with Ringer's Acetate solution.

Interventions

None listed

Sponsors

Klinikum St. Georg gGmbH
Lead SponsorOTHER

Study design

Observational model
COHORT

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age \>=18 years and \<80years * Burned surface area \>20% and \<70% * Burn injury \< 24 hours * Agreement to the study procedures

Exclusion criteria

* Burned surface area \> 70% * Expected survival time \< 24 hours * Acute or chronic heart failure NYHA III or IV * Adult respiratory distress syndrome * Renal failure * Hepatic failure

Design outcomes

Primary

MeasureTime frame
Change of SOFA-score from day 3 to day 7 after severe burn injuryday3, day7, day28, day60

Secondary

MeasureTime frame
Changes in electrolyte-balanceday3, day7, day28

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026